BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 30, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for Jan. 7, 2026

Jan. 7, 2026
Clinical updates, including data readouts and publications: Aclaris, Actuate, Alumis, Apogee, Arrowhead, Astrazeneca, Bright Minds, Cognition, Compass, Demerx, Encellin, Huyabio, Idorsia, Iksuda, Johnson & Johnson, Metavia, Nanjing Delova, Novabridge, Seres.
Read More

Financings for Jan. 7, 2026

Jan. 7, 2026
Biopharmas raising money in public or private financings, including: IGC.
Read More

Appointments and advancements for Jan. 7, 2026

Jan. 7, 2026
New hires and promotions in the biopharma industry, including: Alloy, Alvotech, Artbio, Atsena, Biolojic, Compass, Fractyl, Galecto, LB, Mezzion, Nanology, Outlook, Remix, Repligen, Splicebio, Spyglass, Syncromune.
Read More

Appointments and advancements for Jan. 7, 2026

Jan. 7, 2026
New hires and promotions in the med-tech industry, including: Archeus Technologies, Capstan Medical, Dexcom, Forj Medical, GE Healthcare, Insight Molecular Diagnostics, Next Gen Diagnositics, Radnet, Sensus, Surgibox, Tolion, Truvian, Viz.ai, Vygon.
Read More

Financings for Jan. 7, 2026

Jan. 7, 2026
Med-tech firms raising money in public or private financings, including: Alpha Aesthetics Partners, Corsera, Imvaria, Spiro Medical Inc.
Read More

In the clinic for Jan. 7, 2026

Jan. 7, 2026
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sera Prognostics.
Read More

Other news to note for Jan. 7, 2026

Jan. 7, 2026
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cairn Surgical, CSA Medical, Cordica Medical, J&J, Sophia Genetics, Team Technologies.
Read More

Regulatory actions for Jan. 6, 2026

Jan. 6, 2026
Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Altimmune, GH Research, GSK, Humacyte, Idorsia, Kelun-Biotech, Maplight, Moderna, Protagonist, Sanofi, Scinopharm, Takeda.
Read More

Other news to note for Jan. 6, 2026

Jan. 6, 2026
Biopharma happenings, including deals and partnerships, and other news in brief: Canurta, Hatchtech, Halozyme, Pelthos, Pharmadrug, Skye.
Read More

In the clinic for Jan. 6, 2026

Jan. 6, 2026
Clinical updates, including data readouts and publications: Bioinvent, Crinetics, Incyte, Marker, Neumora, Soleno, Zenas.
Read More
Previous 1 2 … 81 82 83 84 85 86 87 88 89 … 1814 1815 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • Subsense BCI platform

    Next wave of BCI firms builds on pioneers to tackle challenges

    BioWorld
    With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
  • Handshake with DNA, molecules

    Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement

    BioWorld Science
    Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
  • Digital brain with dollar sign

    Investors bet on transformative BCI tech for neuro disorders

    BioWorld
    An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing